Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation

Anton S. McCourtie, Alexander S. Farivar, Steven M. Woolley, Heather E. Merry, Patrick S. Wolf, Csaba Szabo, Michael S. Mulligan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Inhibition of the nuclear enzyme poly ribose synthetase (PARS) protects against in vivo lung ischemia reperfusion injury (LIRI). The effectiveness of intratracheal treatment suggests that PARS inhibition may primarily modulate alveolar macrophage (AM) activation. These studies attempted to characterize the effects of PARS on AM activation in response to oxidative stress. Methods: Primary cultures of AM were rendered hypoxic for 2 h and reoxygenated for up to 4 h. Cells were preincubated with INO-1001, a specific PARS inhibitor 1 h prior to hypoxia. Gel shift assays characterized nuclear factor kappa B (NFκB), and enzyme linked immunosorbent assay quantitated chemokine/cytokine protein secretion. Results: Hypoxia and reoxygenation resulted in an increase in the early nuclear translocation of NFκB, and an increase in the secretion of the cytokine tumor necrosis factor-alpha (TNF-α), chemokines macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein one (MCP-1) and cytokine induced neutrophil chemoattractant (CINC). Pretreatment of AM with INO-1001 decreased both the early translocation of NFκB and the production of TNF-α (p < 0.05) and MIP-1α p = 0.02, but did not affect CINC or MCP-1 production. Conclusions: These findings indicate that PARS inhibition in the AM blunts their response to oxidative stress and may help explain the protective effects of intratracheal PARS inhibition in LIRI.

Original languageEnglish (US)
Pages (from-to)141-144
Number of pages4
JournalExperimental and Molecular Pathology
Volume84
Issue number2
DOIs
StatePublished - Apr 2008
Externally publishedYes

Fingerprint

Poly Adenosine Diphosphate Ribose
Alveolar Macrophages
Ligases
NF-kappa B
Cytokines
Oxidative stress
Macrophage Activation
Chemotactic Factors
Reperfusion Injury
Assays
Monocyte Chemoattractant Proteins
Oxidative Stress
Neutrophils
Tumor Necrosis Factor-alpha
Chemical activation
Macrophage Inflammatory Proteins
CXC Chemokines
Lung
Immunosorbents
Ribose

Keywords

  • Alveolar macrophage
  • Chemokines
  • Hypoxia
  • In vitro
  • Lung ischemia reperfusion injury cytokines
  • PARS
  • Reoxygenation

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. / McCourtie, Anton S.; Farivar, Alexander S.; Woolley, Steven M.; Merry, Heather E.; Wolf, Patrick S.; Szabo, Csaba; Mulligan, Michael S.

In: Experimental and Molecular Pathology, Vol. 84, No. 2, 04.2008, p. 141-144.

Research output: Contribution to journalArticle

McCourtie, Anton S. ; Farivar, Alexander S. ; Woolley, Steven M. ; Merry, Heather E. ; Wolf, Patrick S. ; Szabo, Csaba ; Mulligan, Michael S. / Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. In: Experimental and Molecular Pathology. 2008 ; Vol. 84, No. 2. pp. 141-144.
@article{038f70e4ebcf4296886877e0cc6fbd90,
title = "Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation",
abstract = "Background: Inhibition of the nuclear enzyme poly ribose synthetase (PARS) protects against in vivo lung ischemia reperfusion injury (LIRI). The effectiveness of intratracheal treatment suggests that PARS inhibition may primarily modulate alveolar macrophage (AM) activation. These studies attempted to characterize the effects of PARS on AM activation in response to oxidative stress. Methods: Primary cultures of AM were rendered hypoxic for 2 h and reoxygenated for up to 4 h. Cells were preincubated with INO-1001, a specific PARS inhibitor 1 h prior to hypoxia. Gel shift assays characterized nuclear factor kappa B (NFκB), and enzyme linked immunosorbent assay quantitated chemokine/cytokine protein secretion. Results: Hypoxia and reoxygenation resulted in an increase in the early nuclear translocation of NFκB, and an increase in the secretion of the cytokine tumor necrosis factor-alpha (TNF-α), chemokines macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein one (MCP-1) and cytokine induced neutrophil chemoattractant (CINC). Pretreatment of AM with INO-1001 decreased both the early translocation of NFκB and the production of TNF-α (p < 0.05) and MIP-1α p = 0.02, but did not affect CINC or MCP-1 production. Conclusions: These findings indicate that PARS inhibition in the AM blunts their response to oxidative stress and may help explain the protective effects of intratracheal PARS inhibition in LIRI.",
keywords = "Alveolar macrophage, Chemokines, Hypoxia, In vitro, Lung ischemia reperfusion injury cytokines, PARS, Reoxygenation",
author = "McCourtie, {Anton S.} and Farivar, {Alexander S.} and Woolley, {Steven M.} and Merry, {Heather E.} and Wolf, {Patrick S.} and Csaba Szabo and Mulligan, {Michael S.}",
year = "2008",
month = "4",
doi = "10.1016/j.yexmp.2007.11.005",
language = "English (US)",
volume = "84",
pages = "141--144",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation

AU - McCourtie, Anton S.

AU - Farivar, Alexander S.

AU - Woolley, Steven M.

AU - Merry, Heather E.

AU - Wolf, Patrick S.

AU - Szabo, Csaba

AU - Mulligan, Michael S.

PY - 2008/4

Y1 - 2008/4

N2 - Background: Inhibition of the nuclear enzyme poly ribose synthetase (PARS) protects against in vivo lung ischemia reperfusion injury (LIRI). The effectiveness of intratracheal treatment suggests that PARS inhibition may primarily modulate alveolar macrophage (AM) activation. These studies attempted to characterize the effects of PARS on AM activation in response to oxidative stress. Methods: Primary cultures of AM were rendered hypoxic for 2 h and reoxygenated for up to 4 h. Cells were preincubated with INO-1001, a specific PARS inhibitor 1 h prior to hypoxia. Gel shift assays characterized nuclear factor kappa B (NFκB), and enzyme linked immunosorbent assay quantitated chemokine/cytokine protein secretion. Results: Hypoxia and reoxygenation resulted in an increase in the early nuclear translocation of NFκB, and an increase in the secretion of the cytokine tumor necrosis factor-alpha (TNF-α), chemokines macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein one (MCP-1) and cytokine induced neutrophil chemoattractant (CINC). Pretreatment of AM with INO-1001 decreased both the early translocation of NFκB and the production of TNF-α (p < 0.05) and MIP-1α p = 0.02, but did not affect CINC or MCP-1 production. Conclusions: These findings indicate that PARS inhibition in the AM blunts their response to oxidative stress and may help explain the protective effects of intratracheal PARS inhibition in LIRI.

AB - Background: Inhibition of the nuclear enzyme poly ribose synthetase (PARS) protects against in vivo lung ischemia reperfusion injury (LIRI). The effectiveness of intratracheal treatment suggests that PARS inhibition may primarily modulate alveolar macrophage (AM) activation. These studies attempted to characterize the effects of PARS on AM activation in response to oxidative stress. Methods: Primary cultures of AM were rendered hypoxic for 2 h and reoxygenated for up to 4 h. Cells were preincubated with INO-1001, a specific PARS inhibitor 1 h prior to hypoxia. Gel shift assays characterized nuclear factor kappa B (NFκB), and enzyme linked immunosorbent assay quantitated chemokine/cytokine protein secretion. Results: Hypoxia and reoxygenation resulted in an increase in the early nuclear translocation of NFκB, and an increase in the secretion of the cytokine tumor necrosis factor-alpha (TNF-α), chemokines macrophage inflammatory protein (MIP-1α), monocyte chemoattractant protein one (MCP-1) and cytokine induced neutrophil chemoattractant (CINC). Pretreatment of AM with INO-1001 decreased both the early translocation of NFκB and the production of TNF-α (p < 0.05) and MIP-1α p = 0.02, but did not affect CINC or MCP-1 production. Conclusions: These findings indicate that PARS inhibition in the AM blunts their response to oxidative stress and may help explain the protective effects of intratracheal PARS inhibition in LIRI.

KW - Alveolar macrophage

KW - Chemokines

KW - Hypoxia

KW - In vitro

KW - Lung ischemia reperfusion injury cytokines

KW - PARS

KW - Reoxygenation

UR - http://www.scopus.com/inward/record.url?scp=40949116390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949116390&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2007.11.005

DO - 10.1016/j.yexmp.2007.11.005

M3 - Article

C2 - 18206870

AN - SCOPUS:40949116390

VL - 84

SP - 141

EP - 144

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 2

ER -